Joanne Stekler

Adjunct Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Adjunct Professor, Global Health



BA Biology, Williams College, 1992
MD Medicine (MD), Duke University, 1997
MPH Epidemiology, University of Washington, 2004



University of Washington
Box 359931
Division of Allergy & Infectious Diseases
Harborview Medical Center
325 Ninth Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Joanne Stekler's research centers on HIV testing and HIV prevention. She is a national expert on HIV tests, particularly focused on acute HIV infection and point-of-care testing. She started the first community-based clinic for HIV pre-exposure prophylaxis (PrEP) in Seattle and is currently working to increase access to PrEP and PrEP adherence across Washington State.

Recent Publications (PubMed)

Seroconversion, seroreversion, and serowaffling among participants initiating antiretroviral therapy in Project DETECT.
(2023 Jan 26)
Stekler JD, Violette LR, Niemann LA, McMahan VM, Katz DA, Chavez PR, Clark HA, Cornelius-Hudson A, McDougal SJ, Delaney KP

Could home HIV self-testing ever become a game changer?
(2023 Jan 16)
Clin Infect Dis
Wood BR, Stekler JD

Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs.
(2023 Jan)
Int J Drug Policy 111(): 103924
Austin EJ, Gojic AJ, Bhatraju EP, Pierce KA, Pickering EI, Tung EL, Scott JD, Hansen RN, Glick SN, Stekler JD, Connolly NC, Villafuerte S, McPadden M, Deutsch S, Ninburg M, Kubiniec R, Williams EC, Tsui JI

Perceptions of Sexual Risk, PrEP Services, and Peer Navigation Support among HIV-Negative Latinx and Black Men who have Sex with Men (MSM) Residing in Western Washington.
(2022 Sep)
Sex Res Social Policy 19(3): 1058-1068
Jaramillo J, Pagkas-Bather J, Waters K, Shackelford LB, Campbell RD, Henry J, Grandberry V, Ramirez LF, Cervantes L, Stekler J, Andrasik MP, Graham SM

Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
(2022 Nov 1)
Harm Reduct J 19(1): 121
Barry MP, Austin EJ, Bhatraju EP, Glick SN, Stekler JD, Tung EL, Hansen RN, Williams EC, Gojic AJ, Pickering EI, Tsui JI

Show complete publication list